Results 11 to 20 of about 48,810 (253)

Phenotypes and karyotypes of human malignant mesothelioma cell lines. [PDF]

open access: yesPLoS ONE, 2013
BackgroundMalignant mesothelioma is an aggressive tumour of serosal surfaces most commonly pleura. Characterised cell lines represent a valuable tool to study the biology of mesothelioma. The aim of this study was to develop and biologically characterise
Vandana Relan   +13 more
doaj   +2 more sources

Malignant Peritoneal Mesothelioma Diagnosed by a Laparoscopy : A Case Report [PDF]

open access: yes, 2023
Malignant mesothelioma is rare, and its prognosis is markedly poor. It is often difficult to distinguish malignant mesothelioma from carcinomatous peritonitis of other solid tumors.
品川, 真奈花   +10 more
core   +1 more source

Geographic distribution of malignant mesothelioma incidence and survival in Australia [PDF]

open access: yes, 2022
Objectives: To understand the geographic distribution of and area-level factors associated with malignant mesothelioma incidence and survival in Australia.
Cameron, Jessica K.   +15 more
core   +1 more source

Highlighting the immunohistochemical differences of malignant mesothelioma subtypes via case presentations

open access: yesThoracic Cancer, 2023
Malignant mesothelioma (MM) is a rare tumor of mesothelial cells, with an increasing incidence both in developed and developing countries. MM has three major histological subtypes, in order of frequency, according to the World Health Organization (WHO ...
Anita Sejben   +5 more
doaj   +1 more source

Malignant Mesothelioma [PDF]

open access: yesJournal of the Royal Society of Medicine, 1989
Mesothelioma is a malignant tumour of the pleura or peritoneum caused by asbestos. It is increasing in frequency and the prognosis remains grim, with average survival around 1 year.Medical literature and personal experience.Amphibole fibres are far more potent than chrysotile in causing mesothelioma.A minority view suggests that mesotheliomas in those ...
openaire   +4 more sources

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. [PDF]

open access: yes, 2011
BACKGROUND: The effects of extra-pleural pneumonectomy (EPP) on survival and quality of life in patients with malignant pleural mesothelioma have, to our knowledge, not been assessed in a randomised trial.
Kilburn, L.S.   +59 more
core   +1 more source

Malignant pleural mesothelioma [PDF]

open access: yesAnnals of Oncology, 1998
The incidence of malignant pleural mesothelioma (MPM) has risen for some decades and is expected to peak between 2010 and 2020. Up to now, no single treatment has been proven to be effective and death usually occurs within about 12-17 months after diagnosis. Perhaps because of this poor prognosis, early screening has incited little interest.
P, Baas, H, Schouwink, F A, Zoetmulder
openaire   +4 more sources

Bilateral diffuse pulmonary infiltrates secondary to malignant peritoneal mesothelioma – A rare clinical presentation

open access: yesRespiratory Medicine Case Reports, 2019
Diffuse pulmonary metastasis secondary to primary peritoneal malignant mesothelioma is rarely reported in the literature. In this report we describe a 59-year-old Caucasian women with no known previous asbestos exposure presenting with bilateral diffuse ...
Madeleine Haygarth   +5 more
doaj   +1 more source

Malignant mesothelioma

open access: yesPakistan Journal of Medical Sciences, 2013
Malignant Mesothelioma (MM) is a rare but rapidly fatal and aggressive tumor of the pleura and peritoneum with limited knowledge of its natural history. The incidence has increased in the past two decades but still it is a rare tumor. Etiology of all forms of mesothelioma is strongly associated with industrial pollutants, of which asbestos is the ...
Ishtiaq, Ahmed   +2 more
openaire   +2 more sources

Unusually Aggressive Presentation of Malignant Peritoneal Mesothelioma: Two Case Reports [PDF]

open access: yes, 2022
Malignant peritoneal mesothelioma is a rare disease. Patients mainly present with abdominal distension, pain, nausea, and weight loss with or without an exposure history of asbestos.
Dominik Neff   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy